Related Experiment Videos
Outcomes after carotid artery stenting and endarterectomy in the Medicare population
Fen Wei Wang1, Dennis Esterbrooks, Yong-Fang Kuo
1Cardiac Center, Department of Medicine, Creighton University, 3006 Webster Street, Omaha, NE 68131, USA. FenWeiWang@Creighton.edu
Insights
Carotid artery stenting (CAS) showed similar stroke risk but higher mortality compared to carotid endarterectomy (CEA). Higher baseline risk in CAS patients may explain the increased mortality. Further research is needed.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Interventional Cardiology
Background:
- Carotid artery stenting (CAS) is an established alternative to carotid endarterectomy (CEA) for preventing strokes.
- The comparative effectiveness and safety of CAS versus CEA remain subjects of ongoing clinical investigation.
Purpose of the Study:
- To compare the outcomes of CAS and CEA in a large Medicare population.
- To evaluate stroke, myocardial infarction, and mortality rates associated with both procedures.
Main Methods:
- Analysis of 10,958 Medicare patients aged 66+ from 2004-2006.
- Comparison of in-hospital and 1-year outcomes, including stroke and mortality rates.
- Utilized Cox multivariable models and sensitivity analyses to adjust for confounding variables.
Main Results:
- CAS patients exhibited a higher baseline risk profile, with more comorbidities like coronary and peripheral arterial disease, heart failure, and renal failure.
- In-hospital and 1-year stroke rates were similar between CAS and CEA groups (P=0.14 and P=0.12, respectively).
- One-year all-cause mortality was significantly higher in the CAS group compared to the CEA group (9.9% vs 6.1%, P<0.001).
Conclusions:
- CAS is associated with similar stroke risk but increased 1-year mortality compared to CEA.
- The higher mortality observed in CAS patients may be attributed to their greater baseline risk profile.
- Symptomatic status at the time of revascularization was identified as a significant factor for stroke risk.
Background And Purpose:
Carotid artery stenting (CAS) is an alternative to carotid endarterectomy (CEA) for stroke prevention. The value of this therapy relative to CEA remains uncertain.
Methods:
In 10 958 Medicare patients aged 66 years or older between 2004 and 2006, we analyzed in-hospital, 1-year stroke, myocardial infarction, and death rate outcomes and the effects of potential confounding variables.
Results:
CAS patients (87% were asymptomatic) had a higher baseline risk profile, including having a higher percentage of coronary and peripheral arterial disease, heart failure, and renal failure. In-hospital stroke rate (1.9% CAS versus 1.4% CEA; P=0.14) and mortality (CAS 0.9% versus 0.6% CEA; P=0.20) were similar. By 1 year, CAS patients had similar stroke rates (5.3% CAS versus 4.1% CEA; P=0.12) but higher all-cause mortality rates (9.9% CAS versus 6.1% CEA; P<0.001). Using Cox multivariable models, there was a similar stroke risk (hazard ratio, 1.28; 95% CI, 0.90-1.79) but CAS patients had a significantly higher mortality (HR, 1.32; 95% CI, 1.02-1.71). Sensitivity analyses suggested that unmeasured confounders could be responsible for the mortality difference. In multivariable analysis, stroke risk was highest in the patients symptomatic at the time of revascularization.
Conclusions:
CAS patients had a similar stroke risk but an increased mortality rate at 1 year compared with CEA patients, possibly related to the higher baseline risk profile in the CAS patient group.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Cardiomyopathy VII: Pre and Post Operative Nursing Management